- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/12 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
Patent holdings for IPC class C07D 215/12
Total number of patents in this class: 449
10-year publication summary
|
26
|
26
|
41
|
24
|
33
|
22
|
20
|
26
|
14
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4742 |
10 |
| Merck Patent GmbH | 5728 |
10 |
| Ohio State Innovation Foundation | 2375 |
6 |
| Sun Pharma Advanced Research Company Ltd. | 190 |
6 |
| Hendrix College | 17 |
6 |
| VALO Health, Inc. | 193 |
6 |
| The Regents of the University of California | 20745 |
5 |
| Katholieke Universiteit Leuven | 1283 |
5 |
| Vib VZW | 905 |
5 |
| The Board of Regents of the University of Texas System | 2296 |
5 |
| Agc, Inc. | 5524 |
5 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 318 |
5 |
| Novartis AG | 10262 |
4 |
| Samsung Display Co., Ltd. | 38627 |
4 |
| Toray Industries, Inc. | 7113 |
4 |
| The Scripps Research Institute | 1344 |
4 |
| SpringWorks Therapeutics, Inc. | 156 |
4 |
| The Royal Institution for The Advancement of Learning / McGill University | 713 |
4 |
| F. Hoffmann-La Roche AG | 7837 |
3 |
| LG Chem, Ltd. | 17921 |
3 |
| Other owners | 345 |